Mario Widel

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

Robert J. Heine, Luc F. Van Gaal, Don Johns et al. · Annals of Internal Medicine · 2005 · 794 citations

Expression of a Mutant Form of the Ferritin Light Chain Gene Induces Neurodegeneration and Iron Overload in Transgenic Mice

Rubén Vidal, Leticia Miravalle, Xiaoying Gao et al. · Journal of Neuroscience · 2008 · 108 citations · Full text

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

Vinod Mattoo, D.J.A. Eckland, Mario Widel et al. · Clinical Therapeutics · 2005 · 93 citations

Obesity, Metabolic Syndrome, Diabetes Management +10

Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes

Antonio Ceriello, Don Johns, Mario Widel et al. · Diabetes Care · 2005 · 70 citations · Full text

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

Meng H. Tan, N. Bradly Glazer, Don Johns et al. · Current Medical Research and Opinion · 2004 · 25 citations